The high mutation rate in advanced brain tumors, recent functional studies,
and the high frequency of mutations in prostate metastases all strongly su
ggest that PTEN/MMAC1 alterations are involved in the formation of metastas
es, We searched for genetic alterations in the PTEN/MMAC1 gene in 56 consec
utive brain metastases from various primary tumors by loss of heterozygosit
y (LOH), direct sequence analysis, and differential PCR analysis. The highe
st LOH rates were detected in metastases deriving from lung (67%) and breas
t (64%) cancers. Three (25%) of the eight detected inactivating mutations (
one nonsense mutation, one splice-site mutation, one Il-bp deletion, and fi
ve homozygous deletions) were found in metastases originating from 12 diffe
rent lung carcinomas, suggesting that PTEN/MMAC1 alterations may play a rol
e in the progression of this tumor, With the exception of lung carcinomas,
our findings indicate that genetic abnormalities of the PTENM/MMAC1 gene ar
e only involved in a relatively small subset of brain metastases, However,
the discrepancy between the high overall LOH rate (50%) and the low frequen
cy of PTEN/MMAC1 mutation detection rate (14%) suggests the presence of one
or more additional tumor suppressor genes on chromosome 10q.